Abstract
It has been suggested that biofilm formation by uropathogenic Escherichia coli (UPEC) isolates is associated with recurrence and persistence of urinary tract infection (UTI). We compared the in vitro biofilm formation of UPEC isolates from children with acute or recurrent UTI. Employing 206 consecutive clinical UPEC isolates from children with proven UTI, i.e., pyelonephritis (n = 78), recurrent pyelonephritis (n = 10), cystitis (n = 84) or recurrent cystitis (n = 34), we applied 1 % crystal violet staining to polystyrene microtitre plates at 72 h and measured the optical density (OD) values. The method had been validated to measure biofilm formation against confocal laser scanning microscopy and scanning electron microscopy. The OD values were lower in the recurrent cystitis group than in the other groups (mean OD 0.36, SD 0.21 vs mean 0.47, SD 0.36, P = 0.04) and higher in the recurrent pyelonephritis group than in the other groups (mean OD 0.69, SD 0.33 vs mean OD 0.44, SD 0.34, P = 0.006) indicating biofilm formation of strains causing recurrent pyelonephritis. It appears that the properties of UPEC isolates required for effective biofilm growth on an abiotic surface are important for recurrent pyelonephritis, but not for recurrent cystitis. It would be valuable in the future to analyze whether the biofilm properties of E. coli observed in vitro predict a slower clinical response to antimicrobial treatment and increased renal scar formation after UTI.
Similar content being viewed by others
References
Freedman AL (2005) Urologic diseases in North America Project: trends in resource utilization for urinary tract infections in children. J Urol 173(3):949–954
Shaikh N, Morone NE, Bost JE, Farrell MH (2008) Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J 27(4):302–308
Conway PH, Cnaan A, Zaoutis T, Henry BV, Grundmeier RW, Keren R (2007) Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 298(2):179–186
Nuutinen M, Uhari M (2001) Recurrence and follow-up after urinary tract infection under the age of 1 year. Pediatr Nephrol 16(1):69–72
Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ (2003) Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301(5629):105–107
Rosen DA, Hooton TM, Stamm WE, Humphrey PA, Hultgren SJ (2007) Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 4(12):e329
Blango MG, Mulvey MA (2010) Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother 54(5):1855–1863
Hunstad DA, Justice SS (2010) Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu Rev Microbiol 64:203–221
Soto SM, Smithson A, Martinez JA, Horcajada JP, Mensa J, Vila J (2007) Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J Urol 177(1):365–368
Goller CC, Seed PC (2010) Revisiting the Escherichia coli polysaccharide capsule as a virulence factor during urinary tract infection: contribution to intracellular biofilm development. Virulence 1(4):333–337
Salo J, Sevander JJ, Tapiainen T et al (2009) Biofilm formation by Escherichia coli isolated from patients with urinary tract infections. Clin Nephrol 71(5):501–507
Hannula A, Venhola M, Renko M, Pokka T, Huttunen NP, Uhari M (2010) Vesicoureteral reflux in children with suspected and proven urinary tract infection. Pediatr Nephrol 25(8):1463–1469
Jodal U, Lindberg U, Lincoln K (1975) Level diagnosis of symptomatic urinary tract infections in childhood. Acta Paediatr Scand 64(2):201–208
Benador N, Siegrist CA, Gendrel D et al (1998) Procalcitonin is a marker of severity of renal lesions in pyelonephritis. Pediatrics 102(6):1422–1425
Rediske AM, Roeder BL, Brown MK et al (1999) Ultrasonic enhancement of antibiotic action on Escherichia coli biofilms: an in vivo model. Antimicrob Agents Chemother 43(5):1211–1214
Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1(8476):307–310
Ejrnaes K, Stegger M, Reisner A et al (2011) Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: phylogenetic groups, virulence factors and biofilm formation. Virulence 2(6):528–537
Koljalg S, Truusalu K, Vainumae I, Stsepetova J, Sepp E, Mikelsaar M (2009) Persistence of Escherichia coli clones and phenotypic and genotypic antibiotic resistance in recurrent urinary tract infections in childhood. J Clin Microbiol 47(1):99–105
Soto SM, Smithson A, Horcajada JP, Martinez JA, Mensa JP, Vila J (2006) Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli. Clin Microbiol Infect 12(10):1034–1036
Melican K, Sandoval RM, Kader A et al (2011) Uropathogenic Escherichia coli P and Type 1 fimbriae act in synergy in a living host to facilitate renal colonization leading to nephron obstruction. PLoS Pathog 7(2):e1001298
Schembri MA, Klemm P (2001) Biofilm formation in a hydrodynamic environment by novel fimh variants and ramifications for virulence. Infect Immun 69(3):1322–1328
Norinder BS, Koves B, Yadav M, Brauner A, Svanborg C (2012) Do Escherichia coli strains causing acute cystitis have a distinct virulence repertoire? Microb Pathog 52(1):10–16
Naves P, Del PG, Huelves L et al (2008) Correlation between virulence factors and in vitro biofilm formation by Escherichia coli strains. Microb Pathog 45(2):86–91
Jantunen ME, Siitonen A, Koskimies O et al (2000) Predominance of class II papG allele of Escherichia coli in pyelonephritis in infants with normal urinary tract anatomy. J Infect Dis 181(5):1822–1824
Honkinen O, Lehtonen OP, Ruuskanen O, Huovinen P, Mertsola J (1999) Cohort study of bacterial species causing urinary tract infection and urinary tract abnormalities in children. BMJ 318:770–771
Hannula A, Venhola M, Perhomaa M, Pokka T, Renko M, Uhari M (2011) Imaging the urinary tract in children with urinary tract infection. Acta Paediatr 100:e253–e259
Naves P, Del PG, Huelves L et al (2008) Measurement of biofilm formation by clinical isolates of Escherichia coli is method-dependent. J Appl Microbiol 105:585–590
Cremet L, Corvec S, Batard E et al (2013) Comparison of three methods to study biofilm formation by clinical strains of Escherichia coli. Diagn Microbiol Infect Dis 75:252–255
Gervaix A, Galetto-Lacour A, Gueron T et al (2001) Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection. Pediatr Infect Dis J 20(5):507–511
Smith T, Evans K, Lythgoe MF, Anderson PJ, Gordon I (1996) Radiation dosimetry of technetium-99m-DMSA in children. J Nucl Med 37(8):1336–1342
Roberts KB (2011) Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2–24 months. Pediatrics 128(3):595–610
Acknowledgements
We thank Helga Ylönen for her technical assistance.
Financial support
This work was supported by the Finnish Medical Foundation.
Conflict of interest
None of the authors reports any potential conflicts.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tapiainen, T., Hanni, AM., Salo, J. et al. Escherichia coli biofilm formation and recurrences of urinary tract infections in children. Eur J Clin Microbiol Infect Dis 33, 111–115 (2014). https://doi.org/10.1007/s10096-013-1935-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-013-1935-4